Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prevalence of long-lasting loss of smell and taste after coronavirus disease 2019 infection in Saudi Arabia.

Autor: Allhaiby, Nada¹ (AUTHOR), Allihybi, Sultan² (AUTHOR), Almhmadi, Amir³ (AUTHOR), Alkot, Mohammad⁴ (AUTHOR)

Publikováno v: Journal of Family & Community Medicine. Oct-Dec2023, Vol. 30 Issue 4, p295-299. 5p.

Investigating the efficacy of melatonin, topical sodium citrate, and multivitamin with zinc as a potential treatment for postinfectious loss of smell

Autor: Ellen Cristine Duarte Garcia, Letícia Ribeiro Rosa, Ana Caroline Rodrigues dos Santos, Gabrieli Kaori Alves Ishimatsu, Natália Medeiros Dias Lopes, Marco Aurélio Fornazieri

Publikováno v: Brazilian Journal of Otorhinolaryngology, Vol 90, Iss 6, Pp 101496- (2024)

Objectives: Upper respiratory tract infections, including COVID-19, are associated with olfactory dysfunction and there is a need for novel therapeutic approaches. The aim of study was evaluating the effectiveness of adding melatonin, multivitamin an

Externí odkaz: https://doaj.org/article/53e68c8d571b4c0e96da85166fbb0104

The IL-4-IL-4Rα axis modulates olfactory neuroimmune signaling to induce loss of smell.

Autor: Hara Y; Type 2 Inflammation, Immunology and Inflammation, Sanofi, Cambridge, Massachusetts, USA., Jha MK; Type 2 Inflammation, Immunology and Inflammation, Sanofi, Cambridge, Massachusetts, USA., Huang JY; Precision Medicine and Computational Biology, Sanofi, Cambridge, Massachusetts, USA., Han Y; Precision Medicine and Computational Biology, Sanofi, Cambridge, Massachusetts, USA., Langohr IM; Global Discovery Pathology, Sanofi, Cambridge, Massachusetts, USA., Gaglia G; Precision Medicine and Computational Biology, Sanofi, Cambridge, Massachusetts, USA., Zhu C; Precision Medicine and Computational Biology, Sanofi, Cambridge, Massachusetts, USA., Piepenhagen P; Global Discovery Pathology, Sanofi, Cambridge, Massachusetts, USA., Gayvert K; Molecular Profiling and Data Science, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Lim WK; Molecular Profiling and Data Science, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Asrat S; Immunology and Inflammation, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Nash S; Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Jacob-Nara JA; Global Medical Affairs, Sanofi, Bridgewater, New Jersey, USA., Orengo JM; Immunology and Inflammation, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Bangari DS; Global Discovery Pathology, Sanofi, Cambridge, Massachusetts, USA., de Rinaldis E; Precision Medicine and Computational Biology, Sanofi, Cambridge, Massachusetts, USA., Mattoo H; Precision Medicine and Computational Biology, Sanofi, Cambridge, Massachusetts, USA., Hicks A; Type 2 Inflammation, Immunology and Inflammation, Sanofi, Cambridge, Massachusetts, USA.

Publikováno v: Allergy [Allergy] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.

Validation of a Visual Analog Scale for Loss of Smell as a Quick Test in Chronic Rhinosinusitis With Nasal Polyps.

Autor: Alobid I; Skull Base Unit, ENT Department, Hospital Clínic Barcelona, IDIBAPS, Barcelona University, Barcelona, Catalonia, Spain.; INGENIO, IRCE, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Spain., Calvo-Henríquez C; Rhinology Unit, ENT Department, Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain.; Young-Otolaryngologists of the International Federations of Oto-rhino-laryngological Societies (YO-IFOS) Study Group., Viveros-Díez P; ENT department, University Hospital of Valladolid, Valladolid, Spain., López-Chacón M; Skull Base Unit, ENT Department, Hospital Clínic Barcelona, IDIBAPS, Barcelona University, Barcelona, Catalonia, Spain.; INGENIO, IRCE, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Spain., Rojas-Lechuga MJ; INGENIO, IRCE, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Spain.; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic Barcelona, IDIBAPS, Barcelona, Catalonia, Spain., Langdon C; Skull Base Unit, ENT Department, Hospital Clínic Barcelona, IDIBAPS, Barcelona University, Barcelona, Catalonia, Spain.; INGENIO, IRCE, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Spain., Marin C; INGENIO, IRCE, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Spain., Mullol J; INGENIO, IRCE, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Spain.; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic Barcelona, IDIBAPS, Barcelona, Catalonia, Spain.

Publikováno v: Journal of investigational allergology & clinical immunology [J Investig Allergol Clin Immunol] 2024 Dec 05; Vol. 34 (6), pp. 377-384. Date of Electronic Publication: 2023 Sep 06.